Author:
Németh Krisztina,Palkó Roberta,Kovács Péter,Visy Júlia
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference23 articles.
1. Characterization of the 5-HT2 receptor antagonist MDL 100,907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies;Sorensen;J. Pharmacol. Exp. Ther.,1993
2. Synthesis and in vitro affinities of various MDL 100,907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET;Herth;Bioorg. Med. Chem.,2009
3. [11C]MDL 100,907, a radioligand for selective imaging of 5-HT2A receptors with positron emission tomography;Lundkvist;Life Sci.,1996
4. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain;López-Giménez;Neuropharmacology,1998
5. M-100907 (Aventis);de Paulis;Curr. Opin. Invest. Drugs,2001
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献